Verastem, INC. (VSTM) — 10-Q Filings

All 10-Q filings from Verastem, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Verastem Reports Continued Losses Amidst R&D Focus — Aug 7, 2025 Risk: high
Verastem, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company is still in the clin
Verastem, Inc. Files Q1 2025 10-Q — May 13, 2025 Risk: medium
Verastem, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business activities, including details
Verastem, Inc. 10-Q: Assets $25.3M, Liabilities $40.3M — Nov 6, 2024 Risk: high
Verastem, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $25.281 million and total liabilities of $40.262 mi
Verastem, Inc. Files 10-Q for Q2 2024 — Aug 8, 2024 Risk: medium
Verastem, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported significant research and development expenses, with specific figures not
Verastem, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
Verastem, Inc. (VSTM) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Verastem, Inc. filed a 10-Q report for the period ending March 31, 2024. The

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX